^Farid NR, Szkudlinski MW (2004). „Minireview: structural and functional evolution of the thyrotropin receptor”. Endocrinology. 145 (9): 4048—57. PMID15231707. doi:10.1210/en.2004-0437.
^Calebiro D, Nikolaev VO, Lohse MJ (2010). „Imaging of persistent cAMP signaling by internalized G protein-coupled receptors”. J. Mol. Endocrinol. 45 (1): 1—8. PMID20378719. doi:10.1677/JME-10-0014.
Dodatna literatura
Führer D, Wonerow P, Willgerodt H, Paschke R (1998). „Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism.”. J. Clin. Endocrinol. Metab. 82 (12): 4234—8. PMID9398746. doi:10.1210/jc.82.12.4234.
Farid NR, Kascur V, Balazs C (2000). „The human thyrotropin receptor is highly mutable: a review of gain-of-function mutations.”. Eur. J. Endocrinol. 143 (1): 25—30. PMID10870027. doi:10.1530/eje.0.1430025.
Tonacchera M; Vitti P; De Servi M; et al. (2004). „Gain of function TSH receptor mutations and iodine deficiency: implications in iodine prophylaxis.”. J. Endocrinol. Invest. 26 (2 Suppl): 2—6. PMID12762632.CS1 одржавање: Експлицитна употреба et al. (веза)
Arturi F; Scarpelli D; Coco A; et al. (2004). „Thyrotropin receptor mutations and thyroid hyperfunctioning adenomas ten years after their first discovery: unresolved questions.”. Thyroid. 13 (4): 341—3. PMID12804102. doi:10.1089/105072503321669811.CS1 одржавање: Експлицитна употреба et al. (веза)
Takeshita A; Nagayama Y; Fujiyama K; et al. (1992). „Molecular cloning and sequencing of an alternatively spliced form of the human thyrotropin receptor transcript.”. Biochem. Biophys. Res. Commun. 188 (3): 1214—9. PMID1445355. doi:10.1016/0006-291X(92)91360-3.CS1 одржавање: Експлицитна употреба et al. (веза)
Graves PN, Tomer Y, Davies TF (1992). „Cloning and sequencing of a 1.3 KB variant of human thyrotropin receptor mRNA lacking the transmembrane domain.”. Biochem. Biophys. Res. Commun. 187 (2): 1135—43. PMID1530609. doi:10.1016/0006-291X(92)91315-H.
Nagayama Y; Russo D; Wadsworth HL; et al. (1991). „Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding.”. J. Biol. Chem. 266 (23): 14926—30. PMID1651314.CS1 одржавање: Експлицитна употреба et al. (веза)
Murakami M, Mori M (1990). „Identification of immunogenic regions in human thyrotropin receptor for immunoglobulin G of patients with Graves' disease.”. Biochem. Biophys. Res. Commun. 171 (1): 512—8. PMID1697467. doi:10.1016/0006-291X(90)91423-P.
Heldin NE, Gustavsson B, Westermark K, Westermark B (1992). „A somatic point mutation in a putative ligand binding domain of the TSH receptor in a patient with autoimmune hyperthyroidism.”. J. Clin. Endocrinol. Metab. 73 (6): 1374—6. PMID1955520. doi:10.1210/jcem-73-6-1374.
Libert F; Passage E; Lefort A; et al. (1991). „Localization of human thyrotropin receptor gene to chromosome region 14q3 by in situ hybridization.”. Cytogenet. Cell Genet. 54 (1-2): 82—3. PMID2249482. doi:10.1159/000132964.CS1 одржавање: Експлицитна употреба et al. (веза)
Frazier AL; Robbins LS; Stork PJ; et al. (1991). „Isolation of TSH and LH/CG receptor cDNAs from human thyroid: regulation by tissue specific splicing.”. Mol. Endocrinol. 4 (8): 1264—76. PMID2293030. doi:10.1210/mend-4-8-1264.CS1 одржавање: Експлицитна употреба et al. (веза)
Misrahi M; Loosfelt H; Atger M; et al. (1990). „Cloning, sequencing and expression of human TSH receptor.”. Biochem. Biophys. Res. Commun. 166 (1): 394—403. PMID2302212. doi:10.1016/0006-291X(90)91958-U.CS1 одржавање: Експлицитна употреба et al. (веза)
Nagayama Y, Kaufman KD, Seto P, Rapoport B (1990). „Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor.”. Biochem. Biophys. Res. Commun. 165 (3): 1184—90. PMID2558651. doi:10.1016/0006-291X(89)92727-7.
Libert F; Lefort A; Gerard C; et al. (1990). „Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies.”. Biochem. Biophys. Res. Commun. 165 (3): 1250—5. PMID2610690. doi:10.1016/0006-291X(89)92736-8.CS1 одржавање: Експлицитна употреба et al. (веза)
Cuddihy RM, Bryant WP, Bahn RS (1996). „Normal function in vivo of a homozygotic polymorphism in the human thyrotropin receptor.”. Thyroid. 5 (4): 255—7. PMID7488864. doi:10.1089/thy.1995.5.255.
Bahn RS, Dutton CM, Heufelder AE, Sarkar G (1994). „A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy.”. J. Clin. Endocrinol. Metab. 78 (2): 256—60. PMID7508946. doi:10.1210/jc.78.2.256.
Sunthornthepvarakui T, Gottschalk ME, Hayashi Y, Refetoff S (1995). „Brief report: resistance to thyrotropin caused by mutations in the thyrotropin-receptor gene.”. N. Engl. J. Med. 332 (3): 155—60. PMID7528344. doi:10.1056/NEJM199501193320305.
